Atacand (candesartan cilexetil) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) February 2016 WARNINGS AND PRECAUTIONS Hyperkalemia Concomitant use of ATACAND with drugs that may increase potassium levels may...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts